PYXS 8-K 2026-10-01
Pyxis Oncology, Inc. (PYXS) 8-K dated 2026-10-01 — accession 0001437749-26-031767.
Pyxis Oncology, Inc. (PYXS) is a biotechnology company listed on NASDAQ.
Pyxis Oncology, Inc. filed a 8-K on 2026-10-01. Accession 0001437749-26-031767.
This 8-K covers: Material agreement (Item 1.01), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported PYXS revenue for 2025-12-31 was $13.9M. Net income was -$79.6M. PYXS currently screens at market cap $109.6M.
Not investment advice. The PYXS SEC hub lists recent forms. The stock page is the research view.